USP Center in Ghana Receives International Lab Accreditation - - BioPharm International


USP Center in Ghana Receives International Lab Accreditation

The US Pharmacopeial Convention (USP) has announced that its Center for Pharmaceutical Advancement and Training has received a top international laboratory accreditation. Launched in May 2013 to promote access to good quality medicines, the center is one of the only few laboratories in Sub-Saharan Africa to meet internationals standards in conducting quality control testing of medicines. The center serves all Sub-Saharan Africa—a region facing serious health issues and a proliferation of substandard and counterfeit medicines.

“We serve as a resource to countries throughout Sub-Saharan Africa by equipping regulatory authorities, manufacturers, quality control professionals, and others in the pharmaceutical industry with knowledge and skills to help ensure good quality medicines,” said Patrick Lukulay, PhD, vice-president for the USP department overseeing this effort, in a press release.

“Having an internationally accredited laboratory available as a training facility is a tremendous resource for the entire region,” said Lukulay. “The ISO 17025 accreditation, which came in record time, demonstrates the quality of our programs, the dedication of our staff in Ghana and USP’s commitment to global health.”

The center, located in Accra, Ghana, received the ISO 17025 accreditation from ACLASS, one of the three brands of the ANSI-ASQ National Accreditation Board, an internationally recognized body responsible for granting ISO/IEC accreditations to high quality testing and calibration laboratories. Preparations for obtaining the lab accreditation took place as staff was conducting training programs for regulators and manufacturers in quality control, GMPs, and dossier evaluation.


blog comments powered by Disqus



Pandemic Vaccine Facility Dedicated in Texas
September 19, 2014
GSK Fined in China Bribery Scandal
September 19, 2014
Guideline Delineates How to Implement GS1 Standards to Support DSCSA
September 19, 2014
GPhA Supports Restricted Access Bill
September 18, 2014
Baxter Initiates Voluntary Recall of Potassium Chloride Injection
September 17, 2014
Author Guidelines

Click here